NaNotics

Nanoligent

The company develops targeted protein-drug nanoconjugates for oncology patients to treat metastatic tumours by selectively eliminating cells overexpressing the CXCR4 receptor.

NaDeNo

This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.

COUR Pharma

This clinical-stage biotechnology company develops nanoparticle therapies designed to restore immune tolerance for patients with autoimmune and inflammatory diseases.

Selecta Biosciences

This biopharmaceutical company develops nanoparticle immunomodulatory drugs to treat and prevent human diseases for patients with autoimmune disorders and rare genetic conditions.

PetMedix

PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

EpiBiologics

This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.

ALLEGRO

This company develops nanotechnology-based injectable hydrogel devices to treat osteoarthritis in human and veterinary patients.